Download pdf
Differences of Appearance, Life Cycle, Symptoms, Diagnose and Treatment Mmong Taenia Solium, Taenia Saginata and Taenia Asiatica
- 1 Food Science and Technology, United International College, Zhuhai, 519087, China
- 2 Shandong Rizhao No.1 Middle School, Rizhao Shandong, 276800, China
* Author to whom correspondence should be addressed.
Abstract
Tapeworm belongs to the class Cestoda of the Platyhelminth phylum. In tapeworms, the Taenia solium, Taenia asiatica, Taenia saginata are tapeworm that can infect human and cause taeniasis or other diseases. This essay concludes the basic information of these three kinds of tapeworms including the appearance, life cycle, symptoms, diagnosis, and treatment. In each part it summarizes the similarities and differences among them. The appearance introduces the entire body and gravid proglottid. It compares the length and width in these three kinds of tapeworms, their competence of producing last proglottid, the differences in hooks and the differences in gravid proglottid, which shows general figures of these three kinds of tapeworms. The lifecycle introduces their location and the ways of infection by comparing the differences. In the part of symptoms, the Neurocysticercosis is highlighted and introduce most, and the human immune inhibition is added to complement how human body to confront with tapeworms. In the diagnosis part, microscopical examination, PCR and antibody tests are used to identify the tapeworms. The PCR especially shows the differences of nucleotide sequence and predicted amino acids in tapeworms. For treatment, the similarities and differences in the treatment for different tapeworms are the important contents. Pumpkin seeds and areca nut extract are Chinese medicine, and it shows great power to deworm tapeworms. This essay hopes to get a deeper understanding of tapeworm through the above introduction, so as to promote the prevention and control of tapeworms.
Keywords
Taenia asiatica, tapeworm, Taenia saginata, Taenia solium
[1]. O. World Health, "WHO/FAO/OIE guidelines for the surveillance, prevention and control of taeniosis/cysticercosis,” editor: K. D. Murrell; associate editors: P. Dorny, et al., World Organization for Animal Health, Paris, 2005.
[2]. H. H. Garcia, T. E. Nash,O. H. Del Brutto, "Clinical symptoms, diagnosis, and treatment of neurocysticercosis," The Lancet. Neurology, 13(12), 1202-15 (2014).
[3]. M. Marcin Sierra, M. Arroyo, M. Cadena Torres, et al., "Extraparenchymal neurocysticercosis: Demographic, clinicoradiological, and inflammatory features," PLoS neglected tropical diseases, 11(6), e0005646 (2017).
[4]. F. Mendlovic, A. Fleury,A. Flisser, "Zoonotic Taenia infections with focus on cysticercosis due to Taenia solium in swine and humans," Research in veterinary science, 134, 69-77 (2021).
[5]. A. C. White, Jr., J. L. Molinari, A. V. Pillai, et al., "Detection and preliminary characterization of Taenia solium metacestode proteases," The Journal of parasitology, 78(2), 281-7 (1992).
[6]. V. Rajashekhar, "Solitary cerebral cysticercus granuloma," Epilepsia, 44 Suppl 1, 25-8 (2003).
[7]. S. A. Antoniuk, I. Bruck, L. H. Dos Santos, et al., "Seizures associated with calcifications and edema in neurocysticercosis," Pediatric neurology, 25(4), 309-11 (2001).
[8]. H. L. Yan, G. Xue, Q. Mei, et al., "Calcium-dependent proapoptotic effect of Taenia solium metacestodes annexin B1 on human eosinophils: a novel strategy to prevent host immune response," The international journal of biochemistry & cell biology, 40(10), 2151-63 (2008).
[9]. R. W. Leid, R. F. Grant,C. M. Suquet, "Inhibition of neutrophil aggregation by taeniaestatin, a cestode proteinase inhibitor," International journal for parasitology, 17(7), 1349-53 (1987).
[10]. C. M. Nunes, L. G. Lima, C. S. Manoel, et al., "Taenia saginata: polymerase chain reaction for taeniasis diagnosis in human fecal samples," Experimental parasitology, 104(1-2), 67-9 (2003).
[11]. H. K. Jeon,K. S. Eom, "Molecular approaches to Taenia asiatica," The Korean journal of parasitology, 51(1), 1-8 (2013).
[12]. R. H. Gilman, A. E. Gonzalez, F. Llanos-Zavalaga, et al., "Prevention and control of Taenia solium taeniasis/cystic in Peru," Pathogens and global health, 106(5), 312-318 (2012).
[13]. T. Li, A. Ito, X. Chen, et al., "Usefulness of pumpkin seeds combined with areca nut extract in community-based treatment of human taeniasis in northwest Sichuan Province, China," Acta tropica, 124(2), 152-7 (2012).
[14]. K. Yamane, Y. Suzuki, E. Tachi, et al., "Recent hybridization between Taenia asiatica and Taenia saginata," Parasitology international, 61(2), 351-5 (2012).
[15]. J. F. Rossignol,H. Maisonneuve, "Nitazoxanide in the treatment of Taenia saginata and Hymenolepis nana infections," The American journal of tropical medicine and hygiene, 33(3), 511-2 (1984).
[16]. K. Ohnishi,M. Murata, "Intraduodenal 'Gastrografin' injection against Taenia saginata infection," Lancet (London, England), 336(8719), 880 (1990).
[17]. A. Flisser, "State of the art of Taenia solium as compared to Taenia asiatica," The Korean journal of parasitology, 51(1), 43-9 (2013).
Cite this article
Yue,X.;Zhu,Y. (2023). Differences of Appearance, Life Cycle, Symptoms, Diagnose and Treatment Mmong Taenia Solium, Taenia Saginata and Taenia Asiatica. Theoretical and Natural Science,3,758-764.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
About volume
Volume title: Proceedings of the 2nd International Conference on Biological Engineering and Medical Science (ICBioMed 2022), Part I
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).